Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus
Background and aims: Bromocriptine is a dopaminergic (D2) agonist that has shown hypoglycemic and normotensive activity in preclinical and clinical studies. The main objective of this study was to investigate the effect of bromocriptine plus metformin on glycaemia and blood pressure in patients with...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2018-03-01
|
| Series: | Romanian Journal of Diabetes Nutrition and Metabolic Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjdnmd-2018-0006 |
| id |
doaj-e829fe1d994f477da2aac8792981195d |
|---|---|
| record_format |
Article |
| spelling |
doaj-e829fe1d994f477da2aac8792981195d2021-09-05T14:01:24ZengSciendoRomanian Journal of Diabetes Nutrition and Metabolic Diseases2284-64172018-03-01251596610.2478/rjdnmd-2018-0006rjdnmd-2018-0006Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes MellitusBriones-Aranda Alfredo0Ramírez-Carballo Javier1Gómez Bernardo Alfredo Romero2Villa Victor Manuel Vega3Pérez Manuela Castellanos4Parra Esmeralda Garcia5Santeliz-Montero Hugo Roberto6Faculty of Human Medicine, Autonomous University of Chiapas (UNACH), Tuxtla Gutierrez, Chiapas, MexicoFaculty of Human Medicine, Autonomous University of Chiapas (UNACH), Tuxtla Gutierrez, Chiapas, MexicoFaculty of Human Medicine, Autonomous University of Chiapas (UNACH), Tuxtla Gutierrez, Chiapas, MexicoFaculty of Human Medicine, Autonomous University of Chiapas (UNACH), Tuxtla Gutierrez, Chiapas, MexicoFaculty of Human Medicine, Autonomous University of Chiapas (UNACH), Tuxtla Gutierrez, Chiapas, MexicoFaculty of Nutrition and Food Science, Art and Science University of Chiapas (UNICACH), Tuxtla Gutierrez, Chiapas, MexicoIntegral Hospital “Ángel Albino Corzo”, Jaltenango de la Paz, Chiapas, MexicoBackground and aims: Bromocriptine is a dopaminergic (D2) agonist that has shown hypoglycemic and normotensive activity in preclinical and clinical studies. The main objective of this study was to investigate the effect of bromocriptine plus metformin on glycaemia and blood pressure in patients with type 2 diabetes mellitus (T2DM).https://doi.org/10.2478/rjdnmd-2018-0006bromocriptinetype 2 diabetes mellitusglycaemiaglycated hemoglobindiastolic blood pressure |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Briones-Aranda Alfredo Ramírez-Carballo Javier Gómez Bernardo Alfredo Romero Villa Victor Manuel Vega Pérez Manuela Castellanos Parra Esmeralda Garcia Santeliz-Montero Hugo Roberto |
| spellingShingle |
Briones-Aranda Alfredo Ramírez-Carballo Javier Gómez Bernardo Alfredo Romero Villa Victor Manuel Vega Pérez Manuela Castellanos Parra Esmeralda Garcia Santeliz-Montero Hugo Roberto Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus Romanian Journal of Diabetes Nutrition and Metabolic Diseases bromocriptine type 2 diabetes mellitus glycaemia glycated hemoglobin diastolic blood pressure |
| author_facet |
Briones-Aranda Alfredo Ramírez-Carballo Javier Gómez Bernardo Alfredo Romero Villa Victor Manuel Vega Pérez Manuela Castellanos Parra Esmeralda Garcia Santeliz-Montero Hugo Roberto |
| author_sort |
Briones-Aranda Alfredo |
| title |
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus |
| title_short |
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus |
| title_full |
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus |
| title_fullStr |
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus |
| title_full_unstemmed |
Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus |
| title_sort |
influence of bromocriptine plus metformin treatment on glycaemia and blood pressure in patients with type 2 diabetes mellitus |
| publisher |
Sciendo |
| series |
Romanian Journal of Diabetes Nutrition and Metabolic Diseases |
| issn |
2284-6417 |
| publishDate |
2018-03-01 |
| description |
Background and aims: Bromocriptine is a dopaminergic (D2) agonist that has shown hypoglycemic and normotensive activity in preclinical and clinical studies. The main objective of this study was to investigate the effect of bromocriptine plus metformin on glycaemia and blood pressure in patients with type 2 diabetes mellitus (T2DM). |
| topic |
bromocriptine type 2 diabetes mellitus glycaemia glycated hemoglobin diastolic blood pressure |
| url |
https://doi.org/10.2478/rjdnmd-2018-0006 |
| work_keys_str_mv |
AT brionesarandaalfredo influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus AT ramirezcarballojavier influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus AT gomezbernardoalfredoromero influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus AT villavictormanuelvega influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus AT perezmanuelacastellanos influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus AT parraesmeraldagarcia influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus AT santelizmonterohugoroberto influenceofbromocriptineplusmetformintreatmentonglycaemiaandbloodpressureinpatientswithtype2diabetesmellitus |
| _version_ |
1717810285919600640 |